Clinical Trial Update: Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors [NA]

View source ↗

Summary

This clinical trial compares fractional CO2 laser with Erbium:YAG laser for Genitourinary Syndrome of Menopause in patients using aromatase inhibitors and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Genitourinary Syndrome of Menopause | NA | Status: RECRUITING